Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Anika Therapeutics (ANIK) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Anika Therapeutics (ANIK) over the last 16 years, with Dec 2024 value amounting to $2.3 million.

  • Anika Therapeutics' Interest & Investment Income rose 145.57% to $997,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 9.22%. This contributed to the annual value of $2.3 million for FY2024, which is 1.08% up from last year.
  • Latest data reveals that Anika Therapeutics reported Interest & Investment Income of $2.3 million as of FY2024, which was up 1.08% from $2.3 million recorded in FY2023.
  • Anika Therapeutics' Interest & Investment Income's 5-year high stood at $2.3 million during FY2024, with a 5-year trough of -$302,000 in FY2020.
  • In the last 3 years, Anika Therapeutics' Interest & Investment Income had a median value of $2.3 million in 2023 and averaged $1.8 million.
  • Per our database at Business Quant, Anika Therapeutics' Interest & Investment Income plummeted by 116.12% in 2020 and then spiked by 447.87% in 2022.
  • Yearly analysis of 5 years shows Anika Therapeutics' Interest & Investment Income stood at -$302,000 in 2020, then skyrocketed by 37.75% to -$188,000 in 2021, then spiked by 447.87% to $654,000 in 2022, then surged by 253.52% to $2.3 million in 2023, then grew by 1.08% to $2.3 million in 2024.